MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-13-2025
DURECT Corporation EBITDA per Share 2011-2026 | DRRX
Annual EBITDA per Share DURECT Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.4 | -1.54 | -1.51 | -0.62 | -0.106 | -0.146 | -0.0124 | -0.24 | -0.171 | -0.183 | -0.2 | 0.192 | -0.202 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.192 | -1.54 | -0.472 |
Quarterly EBITDA per Share DURECT Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.13 | - | - | -0.2 | - | - | -0.46 | - | -0.09 | -0.49 | -0.45 | - | -0.04 | -0.04 | -0.04 | - | -0.04 | 0.07 | -0.05 | - | -0.01 | -0.04 | -0.04 | - | -0.01 | -0.04 | -0.05 | - | 0.04 | -0.06 | -0.05 | - | -0.06 | -0.06 | -0.06 | - | -0.05 | -0.04 | -0.04 | - | -0.05 | -0.05 | -0.03 | - | -0.05 | -0.05 | -0.05 | - | -0.05 | -0.04 | 0.35 | - | -0.05 | -0.05 | -0.07 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.35 | -0.49 | -0.0697 |
EBITDA per Share of other stocks in the Drug manufacturers industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-0.32 | - | 7.5 % | $ 6.35 M |  USA |
 |
Assertio Holdings
ASRT
|
1.32 | $ 18.79 | 0.99 % | $ 120 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.16 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-0.86 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
-1.44 | - | - | $ 11.5 B | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
0.22 | $ 3.12 | 1.63 % | $ 43.9 M | USA |
 |
Endo International plc
ENDP
|
1.3 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-2.22 | - | - | $ 36.6 M | USA |
 |
Agile Therapeutics
AGRX
|
-9.17 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
0.27 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
-10 | - | -23.39 % | $ 1.76 M | USA |
 |
Cronos Group
CRON
|
-0.504 | $ 2.56 | 1.59 % | $ 1.33 B |  Canada |
 |
Avadel Pharmaceuticals plc
AVDL
|
-0.42 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
0.16 | - | - | $ 33.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-10.3 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-0.67 | - | 2.45 % | $ 38.1 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
-4.7 | - | - | $ 193 M | Canada |
 |
Bausch Health Companies
BHC
|
6.1 | $ 5.4 | 2.57 % | $ 1.97 B | Canada |
 |
Harrow Health
HROW
|
0.87 | $ 36.41 | 2.75 % | $ 1.34 B | USA |
 |
Aurora Cannabis
ACB
|
-1.67 | $ 3.45 | 2.38 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
-0.89 | $ 1.02 | 3.25 % | $ 110 M | Canada |
 |
PetIQ
PETQ
|
2.8 | - | 1.64 % | $ 400 M | USA |
 |
ProPhase Labs
PRPH
|
1.79 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-1.13 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
0.05 | - | -4.76 % | $ 65.3 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
6.31 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.09 | $ 2.47 | 9.38 % | $ 325 M | USA |
 |
Evolus
EOLS
|
-0.39 | $ 4.13 | 1.23 % | $ 266 M | USA |
 |
OrganiGram Holdings
OGI
|
-0.36 | $ 1.41 | 2.55 % | $ 402 M | Canada |
 |
Emergent BioSolutions
EBS
|
-11.7 | $ 8.34 | 5.97 % | $ 427 M | USA |
 |
Pacira BioSciences
PCRX
|
0.12 | $ 23.17 | 2.84 % | $ 1.07 B | USA |
 |
Sundial Growers
SNDL
|
-71 | $ 1.37 | 4.2 % | $ 3.37 M | Canada |
 |
Tilray
TLRY
|
-2.22 | $ 6.8 | 5.19 % | $ 4.2 B | Canada |
 |
Solid Biosciences
SLDB
|
-2.03 | $ 7.92 | 2.33 % | $ 693 M | USA |
 |
Lannett Company
LCI
|
-3.52 | - | 1.15 % | $ 7.11 M | USA |
 |
Veru
VERU
|
-0.27 | $ 2.54 | 2.42 % | $ 343 M | USA |
 |
Viatris
VTRS
|
2.92 | $ 13.63 | 3.57 % | $ 16.4 B | USA |
 |
OptiNose
OPTN
|
-0.2 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
-1.72 | - | -27.8 % | $ 2.56 M | USA |
 |
cbdMD
YCBD
|
-0.66 | $ 0.71 | 1.83 % | $ 3.06 M | USA |
 |
Relmada Therapeutics
RLMD
|
-1.5 | $ 6.9 | 2.22 % | $ 272 M | USA |
 |
Rockwell Medical
RMTI
|
-0.07 | $ 0.94 | -0.61 % | $ 33.8 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-2.88 | $ 2.31 | 4.52 % | $ 2.87 M | USA |
 |
SCYNEXIS
SCYX
|
-0.32 | $ 0.95 | -0.77 % | $ 47.4 M | USA |
 |
Zomedica Corp.
ZOM
|
-0.08 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.82 | - | - | $ 55.5 M | USA |
 |
Tricida
TCDA
|
-2.97 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-0.4 | $ 0.61 | 0.11 % | $ 2.62 M |  China |
 |
TherapeuticsMD
TXMD
|
-0.35 | $ 2.13 | 5.69 % | $ 24.6 M | USA |